SYNERGY™ XD H7493941808270Recalls & reported problems
Boston Scientific Corporation · Everolimus-Eluting Platinum Chromium Coronary Stent System · Class 3 · Implant
All models of SYNERGY XD (65)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 1
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 08714729980865), received between Dec 5, 2022 and Jan 12, 2026 — classified as 1 death, 3 malfunctions.
The most frequently reported specific device problem is “Break” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
- Break1
- Device-Device Incompatibility1
- Entrapment of Device1
- Failure to Advance1
Patient problems
- No Clinical Signs, Symptoms or Conditions4
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
MalfunctionJan 12, 2026Break
IT WAS REPORTED THAT SHAFT BREAK OCCURRED. A 2.75 X 8MM SYNERGY XD DRUG-ELUTING STENT WAS ADVANCED FOR TREATMENT. HOWEVER, THE PROXIMAL SHAFT OF THE STENT BROKE WHEN GOING INTO THE WIRE. THE DEVICE WAS REMOVED OFF THE WIRE AND COMPLETED THE PROCEDURE WITH ANOTHER OF SAME DEVICE. THERE WERE NO PATIENT COMPLICATIONS.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24042611 ↗MalfunctionNov 27, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
REPORTABLE BASED ON DEVICE ANALYSIS COMPLETED ON 08NOV2024. A 2.75 X 8MM SYNERGY XD DRUG-ELUTING STENT WAS RETURNED WITH NO REPORTED ALLEGATIONS. HOWEVER, INVESTIGATION RESULT REVEALED A STENT DETACH.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 20798299 ↗DeathFeb 28, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THE PATIENT DIED. A 2.75 X 8MM SYNERGY XD DRUG ELUTING-STENT AND LUGE GUIDEWIRE WERE USED DURING PROCEDURE. THE GUIDEWIRE BECAME STUCK ON THE STENT AND THE GUIDEWIRE SHEARED OFF IN THE STENT. ANOTHER STENT WAS PLACED TO TRAP THE GUIDEWIRE IN THE VESSEL WALL. THE PATIENT DIED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18796502 ↗MalfunctionDec 5, 2022Entrapment of Device; Failure to Advance; Device-Device Incompatibility; Entrapment of Device; Failure to Advance; Device-Device Incompatibility
IT WAS REPORTED THAT DEVICE ENTRAPMENT OCCURRED. THE PATIENT PRESENTED WITH ACUTE CORONARY SYNDROME AND UNDERWENT PERCUTANEOUS CORONARY INTERVENTION. THE 80% STENOSED TARGET LESION WAS LOCATED IN THE SEVERELY TORTUOUS AND MILDLY CALCIFIED MID OBTUSE MARGINAL ARTERY. AFTER OBTAINING VASCULAR ACCESS VIA THE RIGHT RADIAL ARTERY, A 6F LONG GUIDEZILLA II GUIDE-EXTENSION CATHETER WAS ADVANCED. A 2.75 X 8MM SYNERGY XD DRUG-ELUTING STENT WAS INTRODUCED BUT HAD DIFFICULTY ADVANCING IN THE GUIDE-EXTENSION CATHETER. FURTHERMORE, DIFFICULT ANATOMY WAS NOTED AS THE RIGHT SUBCLAVIAN ARTERY AND OBTUSE MARGINAL ARTERY WERE VERY TORTUOUS. SUBSEQUENTLY, THE DEVICE FAILED TO CROSS THE LESION AND GOT STUCK ON THE 014 GUIDEWIRE. THE ENTIRE SYSTEM WAS PULLED OUT AS A UNIT AND THE PROCEDURE WAS COMPLETED WITH PLAIN OLD BALLOON ANGIOPLASTY. NO PATIENT COMPLICATIONS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15915488 ↗
Other Coronary drug-eluting stent devices
- SYNERGY™ H7493926038300Boston Scientific Corporation · Coronary drug-eluting stent8 deaths124 reports
- SYNERGY™ H7493926016300Boston Scientific Corporation · Coronary drug-eluting stent7 deaths106 reports
- SYNERGY™ H7493926020300Boston Scientific Corporation · Coronary drug-eluting stent9 deaths90 reports
- SYNERGY™ H7493926016250Boston Scientific Corporation · Coronary drug-eluting stent6 deaths82 reports
- XIENCE Sierra™ 1550350-33Abbott Vascular Inc. · Coronary drug-eluting stent1 recall32 reports
- Resolute Onyx™ RONYX30022UXMedtronic, Inc. · Coronary drug-eluting stent6 deaths76 reports
- SYNERGY™ H7493926024300Boston Scientific Corporation · Coronary drug-eluting stent3 deaths75 reports
- Resolute Onyx™ RONYX30015UXMedtronic, Inc. · Coronary drug-eluting stent3 deaths73 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page